Concepedia

Author

Deborah Zihler

University Hospital of Basel

Also Known As

D. Zihler, Deborah Zihler, Zihler, Deborah

23

Publications

564

Citations

9

H-Index

17

Concepts

All Affiliations

University Hospital of BaselKantonsspital WinterthurKantonsspital GraubündenKantonsspital AarauUniversity Hospital of Lausanne
DZ

About

Deborah Zihler is an author at University Hospital of Basel specializing in oncology, surgical oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

116

2

Surgical Oncology

4

4

116

3

Health Sciences

2

2

72

4

Pathology

2

2

26

5

Immunology

1

1

14

Deborah Zihler

×

9

Publications

512

Citations

9

H-Index

YearCitations

Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors—an autopsy study

Viktor H. Koelzer, Sacha I. Rothschild, Deborah Zihler,

Journal for ImmunoTherapy of Cancer

2016

196

Age‐ and Gender‐Dependent Left Ventricular Remodeling

Cathérine Gebhard, Barbara E. Stähli, Caroline E. Gebhard,

Echocardiography

2013

73

BOB.1, CD79a and cyclin E are the most appropriate markers to discriminate classical Hodgkin’s lymphoma from primary mediastinal large B‐cell lymphoma

Sylvia Hoeller, Deborah Zihler, Inti Zlobec,

Histopathology

2009

72

Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial

Alexandros Papachristofilou, Jens Bedke, Stefanie Hayoz,

The Lancet Oncology

2022

58

Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17

Richard Cathomas, Sacha I. Rothschild, Stefanie Hayoz,

Journal of Clinical Oncology

2023

39

Perioperative chemoimmunotherapy with durvalumab (Durva) in combination with cisplatin/gemcitabine (Cis/Gem) for operable muscle-invasive urothelial carcinoma (MIUC): Preplanned interim analysis of a single-arm phase II trial (SAKK 06/17).

Richard Cathomas, Ulf Petrausch, Stefanie Hayoz,

Journal of Clinical Oncology

2020

32

The Value of Tumour Markers in the Detection of Relapse—Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study

Stefanie Fischer, Christian Rothermundt, Odile Stalder,

European Urology Open Science

2023

16

Perioperative chemoimmunotherapy with durvalumab for operable muscle-invasive urothelial carcinoma (MIUC): Primary analysis of the single arm phase II trial SAKK 06/17.

Richard Cathomas, Sacha I. Rothschild, Stefanie Hayoz,

Journal of Clinical Oncology

2022

14

Safety and efficacy of perioperative cisplatin/gemcitabine (cis/gem) and durvalumab (durva) for operable muscle-invasive urothelial carcinoma (MIUC): SAKK 06/17.

Richard Cathomas, Sacha I. Rothschild, Stefanie Hayoz,

Journal of Clinical Oncology

2021

12

Page 1